Nephros Inc
NEPHNasdaqCIK 1196298HealthcareFiscal year ends Dec 31
Reports and events: 315 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1420:01 ET | DEF 14A | Proxy statementPeriod 2026-10-14 | 0001493152-26-047012 |
| 2026-10-1320:01 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046814 |
| 2026-09-1621:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-26-017130 |
| 2026-08-1020:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036851 |
| 2026-08-0620:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036331 |
| 2026-06-1521:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028539 |
| 2026-05-0720:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-021734 |
| 2026-05-0720:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021701 |
| 2026-04-3020:05 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-020416 |
| 2026-03-2720:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013189 |
| 2026-03-1220:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-009848 |
| 2025-11-2621:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001493152-25-025155 |
| 2025-11-0621:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021061 |
| 2025-08-1120:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022978 |
| 2025-08-0720:39 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022596 |
| 2025-06-1620:15 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-015250 |
| 2025-05-1520:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010836 |
| 2025-05-0820:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009262 |
| 2025-04-3020:15 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007775 |
| 2025-04-2820:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-006427 |
| 2025-04-0101:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-001940 |
| 2025-03-2415:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000234 |
| 2025-03-0621:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009390 |
| 2025-03-0421:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-009035 |
| 2024-11-1421:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045793 |
| 2024-11-1321:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045135 |
| 2024-08-2620:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-033872 |
| 2024-08-0820:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030745 |
| 2024-05-2420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-021342 |
| 2024-05-0920:40 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018483 |
| 2024-05-0920:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018435 |
| 2024-05-0112:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-017355 |
| 2024-04-1220:01 ET | DEF 14A | Proxy statementPeriod 2024-04-12 | 0001493152-24-014442 |
| 2024-03-1520:25 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010107 |
| 2024-03-0721:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-009216 |
| 2023-11-0821:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-039890 |
| 2023-11-0621:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-039516 |
| 2023-08-0920:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027357 |
| 2023-08-0920:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027337 |
| 2023-06-0120:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-019798 |
| 2023-05-1120:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-016374 |
| 2023-05-1020:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016161 |
| 2023-04-2120:01 ET | DEF 14A | Proxy statementPeriod 2023-04-21 | 0001493152-23-013210 |
| 2023-04-0420:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-010797 |
| 2023-03-2321:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-008716 |
| 2023-03-0821:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-007004 |
| 2023-02-0312:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-23-003465 |
| 2023-01-1113:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-001134 |
| 2022-11-2121:01 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-22-033098 |
| 2022-11-1521:27 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032511 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.